Clinical Determinants of Dual Tasking in People With Premanifest Huntington Disease

Alvaro Reyes1, Danielle M Bartlett2, Timothy J Rankin2,3

  • 1Facultad de Ciencias de la Rehabilitacion, Universidad Andres Bello, Santiago, Chile.

Physical Therapy
|January 22, 2021
PubMed

Insights

Dual-tasking is impaired in premanifest Huntington disease (HD). Poor sleep quality worsens cognitive dual-task performance, highlighting the need for sleep assessment in HD management.

Area of Science:

  • Neuroscience
  • Neurology
  • Human Movement Science

Background:

  • Dual-tasking deficits are prevalent in Huntington disease (HD), impacting functional independence.
  • Limited research exists on the determinants and reliability of dual-tasking measures in HD populations.

Purpose of the Study:

  • To investigate clinical determinants of dual-tasking performance in premanifest HD.
  • To assess the association between disease burden and dual-tasking in premanifest HD.
  • To evaluate the reliability of dual-tasking measures in premanifest HD.

Main Methods:

  • Recruited 36 individuals with premanifest HD and 28 healthy controls.
  • Administered single-task and dual-task assessments (cognitive and motor components).
  • Conducted comprehensive clinical, lifestyle, and disease burden assessments.

Main Results:

  • Individuals with premanifest HD showed impaired dual-tasking capacity compared to controls.
  • Poorer sleep quality correlated with increased cognitive dual-task cost.
  • Dual-task measures demonstrated acceptable test-retest reliability in both groups.

Conclusions:

  • Dual-tasking measures are reliable and sensitive in premanifest HD.
  • Poor sleep quality is linked to worse dual-task cognitive performance.
  • Rehabilitation specialists should consider sleep quality in managing dual-tasking deficits in HD.
Abstract